Biofrontera AG
Ansprechpartner: Investor Relations
Tel.: +49 (0) 214 87 63 20
Public disclosure of inside information according to article 17 MAR

Biofrontera AG: Biofrontera AG announces timing of the departure of the CEO

Leverkusen, Germany (pta012/02.12.2021/08:50 UTC+1)

Biofrontera AG (ISIN: DE0006046113) (the "Company") has announced on November 10, 2021, that Prof. Dr. Lübbert has resigned from his position as member of the Management Board effective at the end of May 2022 and that a mutually agreed resignation before end of May 2022 was intended.

The Supervisory Board and Prof. Dr. Lübbert have agreed today that Prof. Dr. Lübbert will leave the Management Board of Biofrontera AG and the management of the German subsidiaries as of December 13, 2021. However, he will continue to serve as Executive Chairman of Biofrontera Inc.

The Supervisory Board is currently considering the future composition of the Management Board of Biofrontera AG.


Emitter: Biofrontera AG
Hemmelrather Weg 201
51377 Leverkusen
Contact Person: Investor Relations
Phone: +49 (0) 214 87 63 20
ISIN(s): DE0006046113 (Share)
Stock Exchange(s): Regulated Market in Dusseldorf, Frankfurt; Free Market in Berlin, Munich, Stuttgart, Tradegate
Other Stock Exchanges: Nasdaq